Earnings call transcript Q4 2022

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good day! And welcome to the GoodRx, Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference call is being recorded.

to conference like speaker, to now Ms. will hand over the your I Investor Manager. Reynolds, Relations Aubrey Senior Please go ahead.

Aubrey Reynolds

quarter XXXX. operator. welcome conference fourth to you, GoodRx’s full Thank Good earnings call afternoon, for everyone and and year the

Co-Founders Joining me Hirsch Chief Executive Doug today our and Voermann, Officer. and Bezdek, Karsten and Officers; Financial Co-Chief Trevor are our

of on objectives, strategies, be Before goals issue we market plans, impact forward-looking remind matters the financial do All anticipated forward-looking made our performance, business, environment statements expected to our relate impact statements. and of statements call not grocer this regarding that business. our the should that the begin, opportunity, everyone I'd or historical to regulatory including of and statements, matters on our of legal the considered the impact on like contain call fact this management's will macroeconomic

promises These achievements or any risks, important performance expressed and implied other unknown statements but actual or forward-looking future are by performance and factors our neither involve different statements. known achievements from uncertainties be cause materially results, These nor factors. results, guarantees, the may to or

and the discussed Annual Report for statements on differ to of indicated in the section December those Securities by year Exchange with filings this our forward-looking ended made cause the XX, XX-K Form Factors actual results the on Risk call. XXXX, and other could Factors Commission materially from

date of to to Any views subsequent this such cause update if forward-looking even the and of statements, events we change. statements as estimates any these management's call, disclaim obligation represent our

that company's found the investors.goodrx.com. replay available our Relations of as nearest call to become there metrics, non-GAAP which overview page everyone shortly which like can GAAP this a at be reference reconciled on addition, In also well. release, we website also metric remind the in press may to will the of I'd Investor earnings certain are

over that, Doug. With I'll to turn it

Doug Hirsch

with operates today. of that progress to healthcare you report and all a affordable for in make joining for made Thank and proud GoodRx Good thank we everyone afternoon, am Aubrey. mission. convenient great clear that XXXX, you, us mission, I on delivering Americans.

$XX the over saved their alone than of XXXX We've medications. more on consumers $XXX $XX billion founding. over In cost million we since our consumers saved

savings For the be lifesaving. support those are life many, adherence we and medication changing can

Before these discussing our incredible performance, highlight and have a the are that recent helping made growth. I possible of the lay to savings want to for accomplishments future foundation few

their GoodRx are on to Today required a we to able leverage Express receive through card with RxNXT automatically with collaboration First, technology discount new into It's Scripts Express as launch prices part. part action acquired members Scripts. no built allegeable of right consumers' their benefits. the pharmacy

which and balance of results, Through encompassing results. seeing early million enroll Health a opens prescription planned we're Cigna, XX business. Express savings the made for participating we’re of this excited continues with their commercial book educate huge great new sponsors across of the program and early TAM segment us over Scripts, up has This all Plans, to Scripts Express Cigna to available positive With lives. to program work

out can health an on the market. plan XXXX we our a other the we plans August Over rolling do coming having survey consciously across months, pharmacies. addressable Based consumers we in reach offering estimate shop. continue of without this to commissioned, to serviceable, as GoodRx benefit to expand way to widely that a With price XX% that now prescription vary of price consumers can not know from the product,

proposition and We've price Express health as provider important most their to and providers. eligible value for price. importantly, who continue a is partners our medication The now generic access for also collaboration the plans payers, than is make benefit eligible benefit getting are expand for members that to GoodRx progress GoodRx we Scripts destination seamless made prices care lower with provider when

We've One value patient a offerings, even by was new to use part way mode. way GoodRx by into who providers, past outcomes. did to enabled as this almost to now these choosing provider delivering brings prescribers flipMD. in more This we are enrolled acquisitions new XXX,XXX such as improve

Lastly, shoppers. network. recently point another retail their pharmacy we've accept added and of value extending forward to Sams XXX Sams network. expanded GoodRx’s our Club to our retail look GoodRx retail core strengthening we discount, locations that network to And our Club proof We pharmacies in

the the But expectations following as the an grocer proud the we resourceful the in While we our mission, of be to opportunity and our us issue than recouped the was yet this XXXX half team that we volume haven't The there the anticipated grocer year in advancing impacted terms of event year results better financial resulting year business performance. is actions much not loss take and with that more first our used from in began exited to resilient, to of were that make event. significantly, issue.

second the conversion adjusted with XXXX, quarter of high cash and expanded consistently line Since EBITDA drove in priorities. our we

with We making. responded am provide more moment. will a but we our how work Trevor pleased do, to have the the actions are team to in progress unexpected our I more challenges details and on

increases, light we uncertainty When expenses, the look close believe incredibly offerings families consumer consumers We economic needs. to and for their to a in current more environment. our facing even remain American healthcare help of with turn their take GoodRx expect at relevant macroeconomic

to the the company relationships it grocer a catalyzed is ensure was success, us entire more year to which our deliver for last our ecosystem. by deeply how as issue our to engage critical even with partners value to and reminder degree A mutual

to with stability. earnings taking complemented and have we to articulated our pharmacy where our constituents, contracts ensure relationships call, we are quarter retailer a third ecosystems PBM we retail hybrid our networks As in approach formalized

of of result pharmacy top increasing partners. many a engagement, with direct have now contracts As prioritizing we our

the future. to X over expect use for million the Our pharma foreseeable we ad subscription our benefit solutions’ the fourth and prescription digital of case GoodRx to quarter, that manufacturer remain consumers from offerings. the to offering end the across and continues shift spending, At

speaks Our relationships resulted of to other engagement quarter. the in both we XX And efforts. for the marketplace. with in the is These prescription consumers, and we to net consumers provide through fourth proportion efforts between by options the over of and start to doubling our the preference value members and deepen and the of the providers platform third our engagement continue the our registered quarter transactions promoter continue end score of fully among the healthcare

create of consumer touch relationship foundation entire on I our us on by believe basket, leveraging strong access. our points long Number Number more to will want touch we HTP two, for the prescription position profitable growth. a our and direct strategy increase increase deep savings to across in briefly areas key including one, relationships. particular, investment four to and built term

choice even and visitors, Number care all PBMs partner will And and providers volume to pharma number our and traffic anticipate they relevance from foot or providers. manufacturers, marketing retailers, for awareness, three, of grow and for higher subscribers PBMs users which the data as four, driving reach be and health for access revenue our our of leveraged across BXB max, pharma, we leading position retailers, further. adherence increase and drive more consumers

another to point. me brings This

with registered we subscription yet who visitors, disclose future deepest us, as growing of strong us. type, for to the have max relationships, we opportunities Subscribers not we engaged relationships. opportunity and well expanding our for max, fully relationships relevance as Regardless create consumer are them. consumers users and our While of rate a have as have view along the spectrum counts, separately a

in looking am further to strategic priorities forward I deliver make continuing our on mission to XXXX. and on our progress

I will call priorities. now to over the and details Trevor quarter our strategic on to provide turn more the on

Trevor Bezdek

Thank you, Doug, and everyone. good afternoon

on we've PBM fourth update and taken to you Before going manufacturer further quarter getting pharma actions retail, strengthen I'm into our relationships. to results, our

issue. were said, headwind Doug to relative due the presented the primarily to unanticipated As aspirations, last from grocer quarters our original disappointing the

However, and span retailer from of applied going even durable we was specifically systems business prescription we transactions and taken No to forward. last the year The PBMs from and offering, have left our crisis our more stone our all our opportunity, structures, entire of first ecosystem and half our and values. steps make shared staff, unturned. comes learning

been mentioned PBM to and announce not relationships. our our strength now across showcasing core retail at the and discount now our hybrid strength. happy are Sams network, Consumers US the implemented Sams low or addition are member. present recent prescription enhancing we prices transactions Club strategy retail locations retailers, Moreover, our the key there a of GoodRx our stability regardless Doug Club greatly Club whether across can Our XXX of access has Sams on medications, and of over

proud the has partners the of churn continuing strengthen and With employees our to our grocer. to I resilience the am our seen network demonstrated helped have at offset we hybrid retail the throughout year. and strategy expand,

efforts engagement fruit. bearing are Additionally, our

of We and of have start is by prescription transactions of proportion the the progress doubled the third quarter, continuing. between registered and fourth quarter the the fully end members

We these of and will relationships. frequent drive which expect LTV more believe higher customized with the engagement will increase registrations consumers, we

that adherence with engagement us, cabinet include we we drive to and by retailers. helps volume the for efforts, These deepen Beyond relevant functionality and for actionable traffic PBMs foot believe offering and medicine are for prescription revenue continuing our consumers transaction consumers, relationships our timely, services for content.

America, our on in the we XX the most competitors on offer medications to medications time analysis. in We top believe pharmacies top of XX% at by the the that prescribed continue prices feeding competitive industry, key our

over repeat new never our stickiness relationships our we with a and being when been a seriously, is XX% position our direct entrant believe We take competitive our function proposition. of transactions of of stronger, the value our space has into

which GoodRx take that stable from millions since value consumers us Our derived has of grocer across leveraging by issue, remained the the the PBMs rates network. demonstrates

the market, year-over-year. pharmacies we up excluding believe from approximately much is approximately the the quarter in COVID excluding vaccine prescriptions X% was across issue. impacts estimate XX.X% approximately grocer increased Volume faster quarter-over-quarter year-over-year, broader the that than fourth We and growth X% which

’XX In the receive our to than help smaller ensure in launched from the we prescription to than efforts we even our addition, a Within registration transaction our engagement past. support expected. transaction to members QX better core represented consistently in platform, initiatives successfully pricing headwind impact offerings volume Gold to relative subscriptions prescription

core launched and incorporating growth initiatives churn, the product gold savings. marketing side, to drive and CRM we to reduce On pricing on price including

and competitive innovation near in will product of fee we delivering user advantage. our growth focus key and product subscription increases. As growth we for initiatives, to sustaining initiatives, We strategic last quarters a is term critical result the will see year’s and lapped the Gold on remain believe come, in one our

the the million X over quarter. public consumers offerings, Across since prescription at transactions end our became and over increase company. This millions, platform of X we an serves a prescriptions of million represents

pockets and providers. pharma comparison, revenue solutions across rolled advertising reach more a our of the manufacturing help Pharma declined year-over-year out engagement quarter solutions in to customers increased of and number patients with We sped against and moderation difficult manufacturers manufactures. a

We several pharma assets for high profile customers. medication exciting products enabled

example, GX pharma more saving our Through manufacturers’ For Dexcom our are GX largest investments the critical work, We further catalyzing new we solutions $XXX for points believe manufacturers. rebates, consumers. growth for critical pain we're and in solutions, in to becoming the solving billion global even and TAM. manufacturers including $XX

and slowing to in quarters secular pharma our increasingly ahead. term in manufacturer shifts years and fourth runway is strong sales quarter, the starting in some digital believe long. growth we marketing over decision and the tailwinds Despite the long very We anticipate making as spend

beneficial saw mode. In to with strong are providers brand in increasingly engaged provider providers I'm fourth our technology, the those connect GoodRx we provider partners provider and growth mode ways. through particularly in XXX,XXX engaging building with we quarter turn capabilities, about us and almost new excited

enthusiastic these our what and forward are I could solutions more more our into growing mode on pharma sharing and There between synergies and about platform, to has XXXX. we momentum not significant our be achieved. provider manufacturers’ team look initiatives

our highlights. million. of top $XXX revenue of above fourth were was but guidance adjusted to revenue EBITDA to XX% Turning of $XXX $XXX.X end quarter down million represented $XX quarter was and million the ahead Efficiency for Total XX% of gains year-over-year, million fourth of also driven marketing productivity. of improve guidance. efficiencies EBITDA by our margin actions to Adjusted a approximately approximately our

consistent $XX.X compared $XX.X quarter, flow marketing and quarter the and our in was by our cash came XX% in activities million third the Sales in at to revenue third quarter. million, of provided operating with

initiatives will We adjusted as to the drive the goal we and our with we macro adjusted EBITDA in prioritize and term, profitability XXXX reality higher cash advancing believe expect on shareholder certainty. During pay growth with value. we that well of mission We focused that and innovations as new conversion. back the investments maximizing remain near will sooner

are our benefits Scriptcycle our underlies capabilities collaboration, integrated with three retail increasing manufacturer early that marketing as acquisitions last savings Along our hybrid which acquisition, our and realizing exciting years, assurance over we RxNXT solutions in the our critical, our vitaCare and Scripts contracting technology which strategy, and PBM focus as success made includes that of the support very Express efficiency, offering. access contributes branded pharma our to well in drugs, on

focus an our taken including our structure and example ability to have model, drive wheel, mobile asset impact facing and to Care while experience. consumer Care backend specific actions app. end user maintaining efficiency, light We GoodRx technology website focusing our the while divesting our of positively is This on expense to GoodRx simultaneously and

the to on quarter in build Our relative EBITDA focused tactical the prioritization we've the margin adjusted second strategic and improvement XXXX positioned achieved future. of us to has

we our retail and headwinds PBM expansion and foundation the stabilization and increasing the laid in customers, of strengthened move to growth as are have year-over-year grocer we confident XXXX. model, business of the returning we add We quarter closer and to fourth revenue lapping pharma our to the network value have the our manufacturers for

to value mission remain of growth, make to for levels EBITDA accessible We driving more revenue shareholders. and healthcare and and historical margin our affordable to on executing to to our adjusted our Americans committed returning

and our I'll over turn that, Karsten With financial it to to discuss results guidance.

Karsten Voermann

revenue $XXX $X was Trevor. down ahead Thank our but of quarter Prescription of transactions year-over-year year-over-year XX% to to also the million for million, guidance Total $XXX.X approximately which million, our to growth million. XX% $XXX.X exceeded you, $XXX revenue by expectations was quarterly decreased million.

The friction than grocer efforts $XX less in again fourth to million impact the expected. approximately engagement million compared to to volume issue from of the estimated revenue our quarter the was XXXX when quarter $XX we was while

for MAC other retailers Y-o-Y, X% $X.X the MAC decreased year-over-year contributed decrease, year-over-year from per PTR grocer. average due X% the of XX% volume shift the historical pricing while scripts than prior low grocer declined volume higher the to approximately to at per all million, arising, issue The at MAC grocer Max PTR quarter-over-quarter. and volume to was in across likely MAC to the consumer of average scripts the pharmacies the grocer per to

year recurring positive see expectations, volume of the growth in pharma fourth offsetting quarter being to revenue arrangements by the customers. impact $XX.X million, the a driven and impact; line partly activity by the in increase from companies, Flu our some the In however from across we did increased manufacturing spending relative focus service prior from prescriptions weather part on December. had market approval part year-over-year our our in and extended a deal declined solutions some timing slight in adverse with latter pharma resulting and periods prioritizing from moderation to across XX%

our X% $XX up term, in growing comp this and to and billion was ability fourth despite extremely is year long optimistic full about growth quarter growth Revenue large this market. quarter-over-quarter challenging the fast revenue last and We up very remain year. business XX%, drive

subscriptions the $XX.X $X of very latest more paid half million churn growing subscriptions, decline to in to expectations membership than implemented and related the members. fee our ahead million, strong, Gold again of offset first increase was the approximately year-over-year as Turning XXXX, XX% revenue

lower the members the expected, priority. the and the Kroger plans ended as increase. XX% fourth given million year-over-year churn members, X plans, X.X reduced continued total quarter as and Savings with both million from of We declined result approximately with pricing its over down sequentially throughout a quarter

increase million primarily increase. personnel of the of and ahead QX $X.X of to year-over-year million, or expectation. $XX.X consumer X% to revenue X% or year-over-year versus Cost in in revenue the X% of support ’XX. related is vitaCare increased $XX.X drove our million acquisition revenue An slightly revenue Other

expense, related partially as lower in and a of costs Product capitalization based development stock headcount fourth of overhead development. by and were driven increases compared to higher allocated and by hosting revenue costs software of in technology with XXXX, or well to expenses party of as $XX.X in XX% $XX.X XX% million or lower result quarter arrangements computing the associated million compensation of cloud revenue as offset third qualified

compared marketing XXXX. Adjusted product Sales of development, $XXX.X revenue expense declined the the fourth quarter-over-quarter. at million or flat million $XX.X expenses XX% X% revenue and $XX.X to of quarter was in were or million $XX.X fourth versus relatively in XX% technology million quarter of and XXXX of approximately

and Trevor our efficiency conversion expenses As proactive and discussed, and the EBITDA current to our response Doug adjusted are we marketing environment, in managing focus. in cash goals

while We continue look brand. our GoodRx will building spend, to the to leverage ways for further marketing still

down was and spend, and marketing to XX% MAC sales stock lower and year-over Despite revenue marketing was increased revenue compensation modestly ago adjusted quarter-over-quarter. XX% in compared Excluding based year our count expense of the items, expense of quarter. other XX% we've year

of expenses in of million fourth revenue stock decrease were the million to of administrative compensation, connection primarily versus non-recurring with or and quarter or General principally by co-CEOs’ $XX.X revenue, $XX.X XX% was XXXX. related IPO. XX% made based driven award in The the

contributor compensation Excluding percentage is X% expense as X% the as percentage stock of compared the percent in other resulting of issue G&A adjusted in grocer adjusted from is revenues. and administrative in XXXX. and decline sales revenue a the The primary expense general expenses to fourth increase the to quarter based items, of

partially $XX.X net was proactively XXXX the and Net loss Adjusted the loss quarter of manage offset investment quarter XXXX. was fourth our spend. by marketing to was $X our fourth compared compared issue of to and million vitaCare, income in in by $XX.X $XX.X million impacted million the grocer ability a to million of in net

million of for we and expectations. driver million the the almost with $XXX ahead impact our for Adjusted adjusted related issue was $XX The estimated of EBITDA to year, flow million, decrease approximately an approximately straight grocer XX% $XX $XXX $XX to the biggest to decline year-over PTR an approximately was to million the to EBITDA. believe has quarter which fourth in year million which through

We in was to a expect adjusted and through the flow business. revenue impact vitaCare points the of of will to continue due grocer drag margin basis from approximately Adjusted XX% integrate the we be down work scale EBITDA margins to as the XXX EBITDA year-over-year falling.

in activities with the are along conversion cash, million million EBITDA our and the of pleased targeted our and resiliency issue growth and forward generated are XXXX. from through to we our $XX.X $XX.X efficiencies key We XXXX. net profitability investments. committed remain driving growing operating we to adjusted since with We quarter going compared a focus fourth will Cash of as progress provided

Our we capital how in role and allocation cash adjusted organizational priorities a are unchanged. are priorities growing our going These play thinking forward. about and realignment critical EBITDA flow

We high the that on most deploy ways to and capital shareholders in and value investments expect focus for quickly. to continue create most projects return

buying Currently, growth, M&As a possibly organic her shares, our back aligns are priorities term priorities. longer sheet, strong and for with investing balance strategic maintaining that

Our and quarter balance remains $XXX.X $XXX.X sheet, and balance on sheet million the debt. the million of strong, in with we outstanding cash ended

to guidance. I'd our about now spend like talking moment a

quarter of ’XX. $XX from fourth first ongoing million, expect $XXX of approximately assumes million revenue prescription transactions million we issue been $XX the approximately of had For the impacts million consistent quarter engagement to with effort which to grocer and the $XXX

volume when have previously, seeing the discussed we’ll as impact until Recall, to grocer XQ a XXXX, expect impact. the issue year-over-year we we lap continue from

to PTR that a per is for quarter-over-quarter show decrease time. expectation modest Our MAC until

year. $XX as million quarter-over-quarter anniversary approximately increases million, fee slightly $XX down the churn of price implemented to from increase are We of nearing decreasing of expect levels last we the subscription revenue

future modest additional be expected may increasingly churn, to We although see we'd in quarters.

fourth due increase ability longer year and in a following and pharma our of quarter quarter manufacturers’ to pattern the expect approval the the ago, our call in We revenue. modestly earnings recognize same the deliver cycles first also resulting on quarter deal to effects first and revenue discussed last continuing as to to solutions delays

million deals From relatively time. and create can and quarterly delivery of solutions, often of this $XX that year-over-year pharma revenue multimillion dollar we As expect a on approximately XX% manufacturers volatility reminder, down large, depending our QX quarter-over-quarter. comprises XX% offering agreement

number of in anticipate a we're future drive on working some the with of have we we manufacturers, engagements which However, sequential growth will quarters. largest

their The and favorable a coming or and this generally me by in and pharma spend outreach coming years. focus HCPs make to sequentially digital, to to quarters about offering macro the digital tailwinds highly continue more optimistic and grow our driving move to over staff more ability manufacturers

quarter. to Finally, we slightly other the million which fourth quarter, first approximately revenue be expect $X is in below the

aggregate, of engagement. the targeted We to to is revenue the scale $XXX that million additional $XXX our In new efforts outlook well investments in retail quickly quarter. as anticipate as first user for expansions, some making million total drive our

key to in in better coming are integrating will be growth a vitaCare, leverage working business our We which also and driver years. pharma the

quarter, earnings our in mean invest call, the to invest opportune while so. so last the the do flexibility said new maintaining we we in marketing, pioneer in can time we're substantially As period fourth didn't to

For fall EBITDA for in mid-XX% reason, margin quarter. our that the the to range expect first adjusted

approximately For margins full range. business entire of million the $XXX and mid-XX million, across $XXX expect EBITDA our adjusted total we year, in revenue to the

As a flexibility the throughout quarter, maintaining make I to priority. year first mentioned and tactical respects with for strategic remains investments the the

On IPO made fourth around that our relating the our of our everyone grants co-CEO in out time like call deployment co-CEOs also to will the the I'd to quarter. delivered to equity capital side, for the be

stock obligation. part exact use figure but million cash the the will expect of to recipient's to tax equity the of range depends We to anticipated to to to price, and cash amount the in $XX authorities. taxes on pay fund million the be cover withhold of The the taxing required $XX

million repurchase remains. $XXX to approximately Finally, the million over I'd share authorization deployment and that also on cash capital side, $XXX like note original

growth platform clear, forward to offerings. term where strategic investments we profitable and deploy brand and profitability our look for Our returning strengthening our for We strategy to and returns the only profile. see and and leveraging to where higher technology proven historical support potential are our capital to to continue long is growth

Trevor closing I'll remarks. to for that, over With turn

Trevor Bezdek

Thanks, Karsten.

on rest on of the look leadership laser our executing priorities. forward As focused year, is realigned to team our the we

growth, our mission, strong create market have see to we are maintain shareholders. pursue share are We durable attractive business ever and before. and on stronger, stable positioned our in We and avenues working We where more growth more to to opportunities. a well today core resilient profitable believe hard efficient, on we for capitalize drive deliver markets, than value those

We been have our now are network our consumers the network value reaching proposition greater. retail never and in look forward partners stabilized our expanding We has and or the to more our to come. on to progress updating quarters you

GoodRx the As our I thank forward work to to at want their opportunities and employees focus and and ahead. moving always, our members we team mission look for hard in forward,

us now today. Thank you to operator the joining for for again over Q&A. turn it I'll

Operator

Thank line first come ISI. Mahaney of you. the will Instructions]. with from question [Operator And today's Mark Evercore

open. is line Your

Mark Mahaney

Thanks. questions, please. Two

what First talked think year? impact, the quantified impacting like sequential help be through of through be throughout QX down? us QX QX there a should for of to it will Will on the impact the grocer year. Looks of this step year. you like you Can about there from and that the of be year also balance qualitatively it last kind

at pace, ’XX comp pace. you do $XXX from about that Should year? also expense could you. founders in about Thank the – Has item? talk this just stock whatever $XXX you ’XX? move similar that's stepped through an it How in and grants, the accelerated at million managing then we to look what step million think down going you And based like as to secondly, that does down

Karsten Voermann

for the Mark, those Mark. is Voermann reverse take I'll Karsten speaking. thanks Sure, in question This order.

com aggregate the at First million of comp quarter stock made in our million approximately point. approximately amounts, co-CEO million $XXX this first grants $XX in million approximately expect of our $X time the XXXX all, we IPO. piece, to stock the $XX around in those of relates for Of and and

And impact issue and course. its we becomes absolute impact, estimate with challenging to the question the precision further get on and to little more a from second grocer as issue, your of further it the grocer

is. So we try big approaches triangulate and estimate couple of a it using analytical how to

we unusual in all quarter, I to and think lap engagement it's show absent the of engagement because in middle the fourth the quarter the but both of impact really reality our it third will the growth, only changes. quarter, be of absolutely is, the effort issue that XXXX third fully grocer first increased the unusual will also cleanest the comp of grocer

right we where grocer That said, see rate. as down a in issue happened, step versus a as we it change the said growth

So step of the that's relatively volume be having why users, seeing as the expected. a of in seeing time meaning dropped versus of over might have down, grocer consistent total them impact and you issue the amounts are overtime you otherwise

So hopefully I’m dig in not happy that's if to helpful, deeper.

Mark Mahaney

Karsten. No, that's great. Thank you,

Operator

from you. our line will come next Thank that question. Draper of One for moment And the Sandy with Guggenheim.

is Your line open.

Mitchell Kellett

exactly about about And how see to to Hi! transactions. it the and just we partnership similar Thank and wanted you. came it This and are any works. if are, the ask regular is details how to more they actually about Mitchell on wanted for Sandy. Cigna economics We how

be more of color kind any Thanks. would So really Cigna on the helpful.

Doug Hirsch

is for Hey there! Thank the Doug. This question. you

We've a makes effort GoodRx. choice invested PBMs marketplace, by is exclusive largest program think program, We for this. the chose they of tremendous be plus is partner their Assure to this be such and we're Express called this powered technology course. the to really Price healthcare of preferred one plus all, excited us the which for and amount time a player of our partner Obviously of as about pricing of us our the partnership that First ecosystem. multi very brand, PBM across great

works. that commercial just Scripts of we their acquired present in Script and/or simply their discount how Basically, So existing really GoodRx. at XXXX, we launched price card provided the eligible, for the it's they is and uses price pharmacy back better it pilot member by technology in the the it the QX, and beautiful and get and an Express Express RxNXT price

out This of payer. claims enables count visibility to towards pocket the claims to gives also of the and full deductible the members’

But We're clear. better This QX. are gone progress, we excited it with So anticipated. momentum. really we I the in early, it's the it's we well. launched with pleased be than to and is performing extremely Again, really, really want

talking we're is rolling think onto as reach – and to Scripts’ pleased planned it. going market address that really expand just Now, sponsors educating bring today, know people with to you more to the try really, even and Express expand We and it's our program opportunity, market. again, we're the

Operator

moment question. come Cowen. One of line for that Rhyee will And with from Thank you. our the Charles next

Your line is open.

Lucas Romanski

seems look streams you sequential to us Lucas the that? we Charles. What I growth is sequential is through to throughout This the to how cadence you're expecting throughout year? the year. revenue When Hi! revenue of about your it then And to guidance, should see walk that going drive at on ramp? that what for imply revenue think contributing we're Can

Karsten Voermann

Sure. for speaking A This things. is again. Karsten Lucas. couple of question the Thanks

talked I continue highest we've our business. significant growth expect of business pharma manufacturer delivering year for first being Y-o-Y lines approximately grew we XX% growth about it than be of think year, at it all, That faster other and results the solutions as a we business to historically, see to full our rate last business.

quarter retailers’ that fact of to increase also our The we've seen the as from overall it third That to our fourth growth referenced contributors quarter. the rate. the non-grocery growth said,

as third might y-o-y quarter well retailers, X% the quarter recollect XX.X%, fourth the on XX% business performing rounded that retailers about growth relative in non-grocery non-grocery the we as about that talked so call about of You at. earnings to seeing growth

prior well. initiative Finally, associated with on Doug the ESI also it are the contributors to question like as Cigna growth seems addressed

largest coming those So think amount growth solutions I in the from, dollar the nominal think are business. manufacturers ordering our from where I the of coming pharma you’d of growth see priority again

Operator

One you. moment America. come with And Cherny Bank of our will Thank from Michael question. the for of line that next

open. is line Your

Michael Cherny

for we side, Good question. Hi! taking afternoon, and I think you're the MAC more, be a in If you've that model what can kick when direct given past of what as of the well have bringing you market thanks think forward, in some adjusted a the the on total should the revenue express the revenue bigger a dive how to dynamics bit contracts about revenue that Scripts, with piece pie. as some gets you especially strong appears per Express we off of how would as direct you're on the think as move said, and going do with about and implied you as per the evolved analyzation seeing pharmacies contracting little that the and grocer of to the MAC become much

Trevor Bezdek

question. the for Thanks Sure.

are I couple of that. there a pieces in think

Cigna initiative Sort as the Doug revenue well about. are doing, impact and per as revenue talked it example, MAC we're MAC the some of that that the things for including per ESI on generally of

marketplace MAC initiative, it think in and model per order, looks of our through our business we that existing revenue those Meaning, from in traditional from and ESI side does our I first taking perspective. business the all the have all associated a like Cigna with backline. our reverse much business flows PBMs

So the identical generate ability off looks revenue business. and to per our all that ways to our revenue MAC normal in material

an who creates aware that that to for have save them. prescription really consumers us distribution, way aren’t does very incremental the of in might prepared particularly and incredibly, remarks, Doug it efficient widely vary actually it money prices as I and on could obliged is the reference XX% they into think what

portion of expanding and automatically SAM automatically TAM. a sources pick is up massively benefit those Since GoodRx from we the revenue. So

will way. other PTR amount terms exactly on perspective, in the a look of a max Those max, Doug PTR to of speculate little early as that max promising. amount are said, we early signs It's MAC more from of generate. that So they to relative per how but the clearly get

of per MAC is With probably grocer's of grocer the a impact the with lower. slight issue There of pricing last the little we've seen associated on – of amount indexing per generally, flux index call, over PTR versus as bit, at this the respect a more volume other the because the calculated that particularly everyone's places, in part year. MAC grocer was to

modeled a declines any you at seeing volatility per or not particular. dollar we're in as percentage non-linearities We or because So anticipating PTR any but that of XXXX MAC, could some on some all. saw there continued in the terms during see year

Operator

One with you. It from line our Craig will come Thank for Morgan Hettenbach of moment question. next Stanley. the

open. is line Your

Craig Hettenbach

then on And as look question Yes, to top conversion, any had a just just of funnel I thank update term you with you. question there? the deeper consumers, getting get just back a longer on you're revenue whether to type might back need help and about plus time. EBITDA how over or you thinking efficiencies it's operational to the XX% you'll there margins growth that other to get any get

Trevor Bezdek

Thank you for the question.

and have found one been margin sufficient Sales we One focused lot there. very as to ways of those and we made expansion, and of significant is marketing year talked we've a that. We've progress prioritizing on about of have optimized and growth areas, that areas marketing. we this optimize is sales the

piece think The we'd talk another area I of that. you engagement, briefly other to like know that's is about

then Doug to I'll have to so of part speak Karsten and your last that question. the have answer I’ll And

Doug Hirsch

Thank Trevor. a obviously is for us. Yeah, engagement priority you, significant

back people brand of originally we you and a when didn't site. us If were on to the so we you go people Iraq, know in good small get know the history tried

drug, we trust find so consumers. know that could You simple a experience, a establish and search value coupon, get for savings, of

If you you – we've this. years been know plus been XX doing it's look forward,

that have higher us. we and a MPS, have drive the we trust, XX and engage to opportunity for We users that LTV have

do that users our I'm we I things. to half had when say the Karsten engage of And have engaged mentioned of fully think we users, proud to those previously attached portion we in transactions as incredibly cool that, ‘XX. doubled could second fully

cabinet. medicine a example, For

our strongly app haven't it you check you I downloaded if out. So recommend recently,

adherence drive pricing medicine a like reminders cabinet or actual see visual your things You refill can the exciting actually of engagement on and app, representation changes. and can notifications for push then your to medicine, do we

too. lift We adherence, patient believe better will that LTV these and better outcomes obviously drive

on So of of really perspective we're I'll for engagement it Karsten excited issues. it. some the to financial really, throw the some about

Karsten Voermann

Thanks Doug, call this On both health reach the that plan the around timing great or expect decisions neither XXXX fourth we XX% marketing it's and quarter time prepared QX start, them. for mid we to plans, works FY’XX year yeah, since earnings ending last mentioned in in off etc. when the consumers a we investments making new on contemplated EBITDA quarter adjusted and make the first and quarter be to our our range. mentioned in as the financial, remarks, we

the those them fresh of making still deductibles in make in the last exploring extensively have didn't quarter, year, we’re the investments consumers now. start We around so as but new

continue focused efficient to delivering be also forward, cash Looking conversions, on really while growth. we driving adjusted EBITDA and

to ways. take that So we're actions drive going value in shareholder continue to those

revenue. also opportunity You've doing. manage an risked, the are asset that limiting hiring headcounts been continued EBITDA, seen percent marketing that GoodRx reduced us experience, Q-over-Q the OpEx for of assets of careful grows. we're more as to you've and consumer and but us with to sell Those are it to off us in EBITDA of and actions support taken through that that seen care we've didn't a led And amount our them maintain reduce light. takes drive impact the even increasing That's as business all dollar that that us

to growth. through longer our From still The us volume over a and time that. a go margins we it'll room do think impact growth bit that is margin take continued a perspective, believe have expand revenue the means issue to we rate and can we we

has incremental cost achieve historically in that means taken, forward fact in our through dollars years margin, to it likely the care and more dollars we’re going has that growth in and base come. than contribute risks, we've both fixed a the ever given to and will now incremental the percent’s the it through other business out initiatives In to able

Craig Hettenbach

you. Thank it. Got

Karsten Voermann

Sure Craig.

Operator

Thank moment the of question. And Eric our for come will you that Sachs. line Sheridan one from with next Goldman

is open. line Your

Eric Sheridan

into – environment come taking people Do to being is possibly savings comment earlier available try understand You about environment? you back make if so a campaigns them made a of the be theme in as to Can better us how from it, we more that app? in on exposed the help aware know, that? how for shift just you how save type Thanks you look of to of savings beneficiary should marketing of more might that front with are downward you the to be consumption in think I how call much there the Sort downward want you to sort maybe in benefiting vertical. on question. run to around around try coupled of macro do you we you volatile, of and capitalize money. to consumers the in a some that terms degree to greater and then your behavior go

us more view beyond. marketing to just platform, dollars awareness how how of build be, and to of to dynamics industry advertising the for industry second looking of continue Thanks little are think continue you would bit broadly a on that term, a who and a if partners about can their budget the give to business color so conversations on with maybe quarter-to-quarter the deploy we products you and dynamic, multiyear long one away from in drive solutions XXXX then And about but marketing thinking evolve much.

Trevor Bezdek

Thank question. you. I the appreciate

bit is help we GoodRx though harder the be definitely an that is for believe where know looks environment macro a This think relative can we like can and it'll You shine, people. environment consumers consumers to where challenges. I with other inflation

one is to going medication of substitute away from. the are people things Fortunately, very last

their prescriptions their they their so help critical on afford so know know afford health for are health. and they consumers rent, purchase can other save can because costs, family's need you their these You things we they to can

to we the albeit is So want do help you there think know, to helpful it people. business, we be to

other of moving The of this on is part from the that COVID. period

normal You challenging to we're others, where know COVID decreased back definitely business new much more and a was our environment. where for it a, certainly prescriptions

in that curtailed. that are of that aspect expanded COVID other being the is though certain now But programs were

for rolled they For access as you out come to would in expect is we Medicaid off Medicaid back needing our tailwind help move people and and business as so example, we services. to that being a Medicaid of certain people also roles, those know states, is are and can

we that know brand. fortunate is, very do How we're amazing have you this

provider mode, it. providers, like consumers have to more our tried has have providers things access we us now largest which healthcare word-of-mouth. to about XXX,XXX remains consumers, innovate the reach of source to access remains activated telling We providers. We healthcare with people It to consumers knowing about

to providers are those in it even activate make We them get workflow. to easier trying and their

continue albeit ways. the can, those marketing, do and do to effectively as to as we efficiently continue We it but are

innovative continuing continue we’ll know, we we're efforts, built. running trust but the benefited product our by largely You marketing running brand and and that

just of which second Relative how dynamic. industry the was evolving part your to budget is and question, the

generally you channels, and pharma I pharma you one with know that the those is in relationships our entities been would manufacturers. would awareness, We so spending know be history. changing. that with know manufacturers would you mentioned PBM, do speak example that the entity for believe the various look network, think we in you strongest When I retail, budget our it's for is industry – with our always

know and the term are you solutions there that We that will in glad – strong of is more. this believe we We basis helpful. this see there think some discuss on that long a year growth manufacturer was very environment to good. Hope

Eric Sheridan

you. Thank

Operator

the line of One Stephanie our moment for you. SVB Leerink. Thank It will Davis question. from come with next

open. is line Your

Stephanie Davis

releases, for factor larger same on base, about so how Is on Kind be [inaudible] will Thanks that the impact into guys a questions. of small and blockbuster it there? consumer something versus the growth that should like the something guys! larger think relatively sort we of how have, for be the could like impactful we year, manufacturer Hey question when or would taking that platform? some is just that of drug my solutions that that

Trevor Bezdek

about at with very year-over-year relationship brand leverage pharma and deep because want healthcare to rapid professionals growth grew and of fast the that year, our thank manufacturer and grow professionals despite and you that access speaking the with continues that awareness. strength of for manufacturers much The I've tough about been is last consumers XX% the to business XQ healthcare We Stephanie. with comp Yeah, and a clip. a

we're XX to we other grow these top adding manufacturers top proud brand, earning relationships we and those those about into we're so continuing XX. more the talked additional have last of more of adding. call. manufacturers, And accounts, outside XX that

of So there, a progress there's good lot lot of a launches.

effectively significantly, the fastest would net those think opportunities. we access great awareness are and significant we is, be total highlight places help and while that mentioned, grow our portion growing drugs the can where area for concentration really don't here. the will the have are business and our I this spend. of we on Those business, year using of will you driving They what But

work with two see across So programs we it. opportunity a so lots meaningfully manufacturers one lot we on But a you programs, products. mentioned of would of like do of program, alone change of lot lot not a here

Stephanie Davis

for thanks. Super one this Karsten And helpful, one. on

I year-over-year, margins looking was surprised in a the Just at see bit to them guidance. compressing little

we changes that you of we mind, think like Kruger with pricing recent how can even think and year? how the – of could and competitive about the So should the dynamics. throughout And in some from and the the moving pieces margins about arc

Karsten Voermann

the here. Karsten thanks Sure, Stephanie, question for

key think managing side. on one the is structure about against growth cost revenue their we I think is number time, margins over as focus

We've preserving, year XQ being deductible I the we're quarter etc. the and plan flexibility given times throughout periods XQ investments. invest for to think good make years, talked about new patients, and for particular the to previously their too. first new in

able be growth and of a Now to that as in so to some percent flexibility, our go invest margin ability as incremental reduced revenue created into growth to quarters. contemplate a the that further refined we a more through we and sales future so see that view investments tradeoffs, than even higher, on, to we of marketing maintain need and to and marketing, have we more is before as with growth continue clearly way drives drive

the showcase growth. is cost when the where faster. to revenue margin Again, we same slope meaning structure as on the more area more be growing show said, the to as does, relative revenue we think moving expansion I able actually will that not

will everyone fourth and the to quarter both So this street see that the be that that's in when we'll be started year, themselves. on engagement lap in QX the able of efforts when for which able we we growth lapped be middle fully the of the will numbers showcase to issue, grocer

here as going expanding a further the we expense expenses how in that on the articulate to show can very keep think trajectory forward, clear carefully those and concentrating we margin in controls way the managing it'll well, it. see I that's mind, with path appropriate years to around come best on to as side probably focus

XQ I margins year range, think continuing the make the in and we're For growth both as those that full see investments as year XX% mid well. for to we drive to

Stephanie Davis

Helpful, thank you.

Trevor Bezdek

Thanks Stephanie.

Operator

with of One that moment And Truist. next come question. the you. Jailendra Thank line from will for our Singh

open. now is line Your

Jailendra Singh

and you, thanks questions. for my Thank taking

in business year. the growth want you pharma a manufacturing So to business where to this seems and is the you of it there, is It expect for the primary think the year? and solutions that QX What the seen like back ramp ramp you stay a will I trends this this beyond year. topic you have rest confidence gives expect visibility driver business of ramp and go that for you in revenue the which

marketing what you great kind And it and arrangement terms to in the share service like if a was in seeing color mean this, would release recurring clients pharma could there related any around spending you be exactly like the Maybe comment what build firstly of respect arrangements? there actual are of among customers. prioritizing you with with your around digital to

Karsten Voermann

This from hear you. Sure well. speaking is to as Jailendra, great Karsten

So if I'll see the can hit all I parts.

in potentially this commented that a that general of one, parts the I of there's being year. two, see how Jailendra as our evolving; a we didn't whether as number wins on I to I generally in there well And three trends number think piece were; the terms we one Y-o-Y third largest growth, dollar growth the the [inaudible] contributor catch?

Jailendra Singh

comments arrangements, prioritizing the there? like around recurring what like service general, think in Just do you

Karsten Voermann

order first. take me reverse one let those in Sure, that hit and

quickly some with the end that I working of manufacturers through CY our be the ’XX, had too their deploy contracts material given ’XX, far piece us quarter most quarter at ways can in others at we revenue the the of to manufacturers and important when amounts to because relative probably that's funds we it the fourth performance significant versus to look we of reality fourth in ’XX of recurring quickly. of think was so one, quite of arrangements, direct agencies, deploy where look could react those budget proportion they them look and quite since big

receive is and that think great it. grateful revenue for I we're to

goes to revenue and is that too. – more particular Stephanie's little question this a However, associated is back a recurring with

I larger versus recurring us, to shareholder to that the being force drugs so deploying continue that's think stream, it around energy the create topped manufacturers around the episodic in was attractive will sales and more revenue other and very stats creates deploying recurring revenue value, year-after-year blockbuster larger that nature. and in each against run have drugs, because our long more more

So the greater we're context, recurring in focus what to I think on referring the revenue. that's

we I $XX very, or looking very solutions TAM see attractive the and penetrated as it manufacturer little at more broadly this still and a we pharma so very business, far. at of think, billion huge so,

continuing reality other to The is happen. the shift is digital to

as data that suggesting some if fact accelerating, In we think see I it's anything.

to digital, in continued shift that opportunity great we see from So perspective too. that

for product and I solutions offer and aspect others focused last more that a vector, the especially of avenue only only existing have growth other medication. seen focused for it helped top Early us since finally, our manufacturers, the provider not more per providers. vectors and of we pharma That us with mode growth is more the think creates on us to of of solutions, are now that's manufacturer we that and business. just increase, more side that on more and manufacturer effectively to in attention capture the launched important relation consumer we've we medications then new HCP draw of the year growth each

contributing gap? through to year. still all the hit manufacturer there growth we I So those a Jailendra questions see or accelerating there's pharm Did solutions attributes the

Jailendra Singh

that’s No, lot. Thanks a perfect.

Karsten Voermann

with you. thanks Great speak Great, Jailendra. to

Operator

Thank the Yong Suisse. you. That Instructions]. Credit One will Jonathan [Operator moment come from line next question. for of our with

open. is line Your

Jonathan Yong

taking Hi! Thanks question for the here.

of kind building made. that on you just comment Just

solutions, Thanks. then You that? manufacturers? in revenue having that that there. any prescribers the with being benefits you guys led Has come you're from maybe manufacturer to increased said you're that alongside conversations that now. has that talk that, are pharma derived the Can up from XXX,XXX in derived And transaction over prescription about

Doug Hirsch

really question. Jonathan, us. of broadly. for you have This a XX provide evidenced this because we patients. And for with value lot providers extremely we them, They've a that score their and by us. referral Thank the the for been an company, channel patients is important NPS source over to Throughout great incredible for been They've is them. for been the have

with the Mode. have Provider the – talking been about launched prescribers we activated we've Provider year, today What is XXX,XXX that we Mode, stat last in now which

you out prescribers are use audience of As materially are are activated GoodRx. XXX,XXX about we providers. of really larger We're Provider Mode. to, But who prescribers now seeing activated that, alluded about in higher because LTVs that’s those a these from who excited

So from you workflow have this manufacturer are that we've the for others tools, and developing and derive to solutions. And these just we primary by saying, through like they even GoodRx them new we are easier make tools their revenue that provide the working. incorporating is building been

on it pharma that important and a that solutions to target awareness, this is spend do of deals selling our a that because it’s year, providers, we our target things, the offering about that's HCVs, a TAM have generalizing But access of been of some us revenue access access HCVs and so and And that that we a from portion great way variety clear so are just manufacturer business, consumers, piece. deals billion $XX for is because different this very to for great so. within manufacturers

patients to their There is, an GoodRx those and at that tools within increase make rate. revenue, about doctors we transactions know recommendations through point, Mode increased helps even that GoodRx which it patients second that are to making tell making Provider is for green this is shoots around use to PTR easier you

Operator

you. Hill Bank. Thank the line of One George our question. with It for comes Deutsche moment next from

line open. is Your

George Hill

I direct contracts. evening about Hey! you can like guess, the maybe talk of I my And impact revenue guys. Good these taking a margin of you big retail percentage question. as and guys how appreciate

kind I that have of PBMs worse the playing think retail you incremental assume these make is a like little – given other. would business. would would the a the off the could we each But direct the that the you multiple commentary balance versus love of contracts bit profile than on on any it margin seems the composite

Trevor Bezdek

history. in changes manufacturer important highlight this is to that – retail largest What’s that the network PBM we've Sure. want really we strongest that we and our make made to sure have

key hybrid strength approach components enhance to implementing this to One network. retailers contracting of is of stability across and those the the

PBM sure the of also in So our order the parties we our all set then of are with needs the meeting to – full PBMs selectively have ecosystem. we work contract we marketplace we make And with. in are these

has direct highlight to think would think I with what remained stable your we So have now take do which, many partners. grocer answers top since question issue. the I pharmacy our contracts of rate I that

of satisfy been So participants. really to to pricing the continue We've have competitive maintain advantage able all we've been to we and able this through multi great network. our PBM maintain

very business. changes we've able and of to term are we pleased think helpful been stability it’s the So long make these that really the for

Karsten Voermann

I'd I think that. add the here quickly Karsten is only George. thing

all The material that really more other the the helping a of us thing contract today. than even contracts is of volume for direct a reason in for is that, business driving at The large is really the corner I'd this volume or significant minority part cases, add not all. are direct majority

George Hill

That's Thank you. helpful.

Operator

question. from Davidson. next our Simmons for come moment One with Robert you. Thank it DA Well

is line open. Your

Robert Simmons

time? and think Hey! of to high I you taking that over you if can doubled Thanks you now good registered question. wondering could get how you my that are do It's penetrated the was fully members. share how proportion for hear

Trevor Bezdek

here better. substantially to to know our spoke the that customers make we to we're focus higher to the early the we indications. getting Thank we and question. are We users from seeing sure as you users trying for get have The mentioned, registrations is real Doug registered. priority Those LTV

of is engaged and that not will users did We're half. we the transactions to attached disclosing think proportion but that registration those that have very increases. opportunities, Doug better we continue where opportunities to LTV new those sell, lots as lots opportunity opportunities alluded to to, opens registries, of and from drive there's fully just in and give functionality, total And of second the base, cross there, up the opportunities we to double encouraging,

the about excited very efforts. we're So engagement

Operator

of One you. will And Thank moment come Steve Barclays. from question. that Valiquette next the our for line with

is Your open. line

Steve Valiquette

thanks. Great, Good afternoon.

So a couple of things.

a has around little service. landscape of Edge. Optum Amazon with Price launching competitive recent The bit First been the RXPass this further Rx revolution subscription news on

really ‘XX just be absorbed or question for from these see would the range, it just range specifically is competitor any, impact you something whether the really new the within offerings Just maybe these had which for you if were adjust guidance now. or the to not way guidance the

of Medicaid from that be you something upside earlier the the the same Thanks. potential into tailwinds those I to on or driver is you something then just would clarify, roll positive of sort specifically Medicaid an the that tailwinds the And off, alluded baked the to the this redeterminations guess range. from on again, relative ’XX to thing call. more are And guidance, side,

Trevor Bezdek

questions briefly then around I'll to I'm going and Karsten speak the to the around answer competition. question have guidance, Doug let

Karsten Voermann

into baked guidance Hi Steve! not. I versus question around your was think what's

baked into everything terms think effectively. In I what's today through guidance, of

considered which environment to a speak further. and we've will competitive that's Doug been evolving, little the how So certainly bit

of folks in rolling states today are about the off everything We've what each and we also Medicaid terms Medicaid. know doing considered of

to incorporated information us available that took in. that and we again, all So we had

Doug Hirsch

Thank Sure. Karsten. you,

think to incredible outcomes. we we simply to on the guide for mentioned call, what Americans who educate opportunity continue which know I such that prices view reiterate as us competition, the better previously to really I want of an vary. them XX% is to our There's consumers as just really and don't

the our competition, the at means only table we drive wonder, three the also our about just which prices. lower set here which core which way frame ones I marketplace were I really we multi strengths, our is is PBM again, scale,

of XX% the competitors point, top data beat time at drugs. one of retailers we most the Just prescribed the XX

suite we're where our of lastly where can we over save exports much a then Obviously XX,XXX in and on at NPS Secondly, dollars. America, good our pharmacies times. virtually is spot few increasingly generics all our we that spoke thousands every breadth, at And medications. pharmacy we for that GoodRx have which plus brand mail, reach, to incredible and pretty again

So strengths potential again, our that's against key competition. and the really competition

a individual and into course to With your really seen releases, over space of years many regard press know the and of focused get look, that we've try has we folks, lot questions Amazon actually to know change. about you to drive the

be impact evidence in about that. seen we've I seen of pretty want no clear have We our on no to and And business. just growth volume,

see than for a business. don't previous they but there, some and drugs, it do as necessarily see had we This latest compelling of of program the impact is on any subset not our direct out offerings so we more

Steve Valiquette

it. Got

thanks. Okay,

Operator

One you. moment question. Dishart [ph] Stephen Thank line our for of come the with Will from next KeyBanc.

line Your is open.

Unidentified Analyst

Hey guys! some Could what Thanks. provide your Subscribers you're with currently Gold seeing you activity? color on

Karsten Voermann

speaking this question. the one This for Karsten is Thanks Sure. again. to

churn Gold, to on So some year. see post our we continue last from price increase

revenue perspective, is elasticity an from way course, up. Of

it of that subscriptions increasing reality we the indicates expected, So much did, the as inelastic largely offering. as in have as our revenue a offering we

our remember, of the over a other way subscriptions done increase we never a price the added and is that of you though of among the inception if years, including had example, just by reality types of offering, significant amount telehealth we value since offerings. discounts particular, have In even

So, time from increase. those the perspectives, to right to like the it was able we felt be do price

I may has curve, seen was said, a have previously, of it to like less year-over-year revenue dramatically the we on some We've half-life the for And seen through quarter. remained this that a we increase. of quarter-over-quarter. doing perspective continue as sort fourth That less part generally think year, that beginning expect continued same gets great churn churn subscriptions the while the price on and the be has our success it increase it way

us. are we're subscriptions So the from performing way for those quite perspectives, I with pleased think

Unidentified Analyst

you. Thank great. Okay,

Operator

our One Mario from Hegar. Louise come line moment next And will you. of Thank the for question.

Unidentified Analyst

Club Hi! for or decremental is ask Louis expect [inaudible]. Kroger Savings on 'XX? for if and you to you. just the any This Thank EBITDA is to update wanted revenue I from renewals if on trends there be that to the

Karsten Voermann

the Karsten This question Louise, for Thanks again. Hi! is Mario.

that what we've by subscriber regard about talked contribution, of users, is adding of So pretty The July on will revenue. with a on that around calls but and I mean users terms XXXX. both count it adding we that small previous KSC, program in is expect still though discontinue to program is tiny, and

To frame Club you Kroger That an between Savings individual family. and think is a Kroger amount the you, a about that for and year when $XX it, up split on and $XX pricing for gets

GoodRx.

So only to portion a of GoodRx. that comes

and a So our a months month, our family pricing is and $XX.XX individual and for $X.XX own plans. we fraction, have

alone, skews plans. price a revenue see perspective of that it from towards So own you can our dramatically

impactful. don't we new material around Club should at impact We financials on a expect not stop Kroger our adding middle all. of Savings So, as users XXXX we it see

Operator

questions this you. well This I'm queue showing Thank you today's time. for session, at today's program. concludes Thank today's question-and-answer no as the as call. conference further all participating in in

disconnect. now You may

GoodRx (GDRX) 28 Feb 232022 Q4 Earnings call transcript